Senior Director, Commercial Planning and Operations at Gilead Sciences

Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Deep understanding of the pharmaceutical industry landscape in China
Proven leadership experience in team development and functional performance management
Expertise in forecasting methodologies and their application to business challenges
Strong analytical skills with the ability to translate data into strategic recommendations
Effective communicator with the ability to engage senior executives and cross-functional stakeholders
Demonstrated ability to manage multiple projects and lead cross-functional teams
Strategic mindset, learning agility, results-driven, and a proactive attitude
Bachelor’s degree in Business Administration, Economics, Finance, or a related field
Fluent in both English and Mandarin

Responsibilities

Lead the development and execution of commercial planning initiatives, including affiliate strategy, pipeline planning, cross-functional strategic projects, and annual business planning
Strengthen analytics capabilities to deliver actionable insights through market research, competitive intelligence, and performance data analysis
Oversee the design and implementation of sales force processes and policies, including target setting, territory alignment, incentive planning and payout, and data management and analytics
Define and execute learning strategies to build and sustain high standards of commercial functional capabilities
Develop and implement Omnichannel Customer Engagement (OMC) strategies, enhance commercial organizational capabilities, optimize the use of platforms such as CRM and Enterprise WeChat, and provide valuable insights through OMC execution and analytics
Partner with GCSO and China cross-functional teams on pipeline assessment, launch readiness, operational excellence, and OMC strategy execution
Collaborate with Finance to lead long-range planning, portfolio reviews, target setting, prioritization, and resource allocation
Drive affiliate-level excellence initiatives aligned with short- and long-term business strategies to maximize resources and achieve commercial goals

Skills

Commercial Planning

Affiliate Strategy

Pipeline Planning

Business Analytics

Market Research

Competitive Intelligence

Performance Data Analysis

Sales Force Effectiveness

Territory Alignment

Incentive Planning

Data Management

Commercial Learning

Omnichannel Customer Engagement

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free